Why Do We Need ADAMTS13?
作者信息
Tsai Han-Mou
机构信息
Division of Hematology Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA, Division of Hematology Montefiore Medical Center (111 East 210 Street Bronx, NY 10467 USA., Tel: 1 718 920 4410.
出版信息
Nihon Kessen Shiketsu Gakkai shi. 2005;16(1):54-69. doi: 10.2491/jjsth.16.54.
Abstract
摘要
相似文献
1
Why Do We Need ADAMTS13?我们为什么需要ADAMTS13？
Nihon Kessen Shiketsu Gakkai shi. 2005;16(1):54-69. doi: 10.2491/jjsth.16.54.
2
Simultaneous exposure of sites in von Willebrand factor for glycoprotein Ib binding and ADAMTS13 cleavage: studies with ristocetin.同时暴露 von Willebrand 因子上的糖蛋白 Ib 结合位点和 ADAMTS13 切割位点：瑞斯托菌素研究。
Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2625-30. doi: 10.1161/ATVBAHA.112.254144. Epub 2012 Aug 23.
3
Structural and functional correlation of ADAMTS13.ADAMTS13的结构与功能相关性
Curr Opin Hematol. 2007 May;14(3):270-6. doi: 10.1097/MOH.0b013e3280d35820.
4
[Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers].[血栓性血小板减少性紫癜患者及携带者中ADAMTS13抗原及其活性的测定]
Zhonghua Xue Ye Xue Za Zhi. 2006 Mar;27(3):154-7.
5
Reduced ADAMTS13 activity is associated with an ADAMTS13 SNP, fever and microparticles in a malaria-like model.在一个类似疟疾的模型中，ADAMTS13活性降低与一种ADAMTS13单核苷酸多态性、发热及微粒有关。
Malar J. 2014 Jan 3;13:3. doi: 10.1186/1475-2875-13-3.
6
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond.用于血栓性血小板减少性紫癜及其他病症的ADAMTS13实验室检测
Semin Thromb Hemost. 2025 Sep;51(6):687-697. doi: 10.1055/s-0044-1792003. Epub 2024 Oct 28.
7
Changes in von Willebrand factor and ADAMTS13 during IVF.体外受精过程中血管性血友病因子和含血小板解聚蛋白和金属蛋白酶13的变化。
Blood Coagul Fibrinolysis. 2011 Mar;22(2):127-31. doi: 10.1097/MBC.0b013e32834363ea.
8
Reduced ADAMTS13 Activity in Correlation with Pathophysiology, Severity, and Outcome of COVID-19: A Retrospective Observational Study.ADAMTS13 活性降低与 COVID-19 的病理生理学、严重程度和结局的相关性：一项回顾性观察研究。
Int J Infect Dis. 2022 Apr;117:334-344. doi: 10.1016/j.ijid.2022.02.019. Epub 2022 Feb 12.
9
Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty.择期关节置换术患者血浆中ADAMTS13和血管性血友病因子水平的变化
J Clin Med. 2022 Oct 30;11(21):6436. doi: 10.3390/jcm11216436.
10
ADAMTS13 activity decreases in the early phase of trauma associated with coagulopathy and systemic inflammation: a prospective observational study.在与凝血病和全身炎症相关的创伤早期，ADAMTS13活性降低：一项前瞻性观察研究。
Thromb J. 2021 Mar 12;19(1):17. doi: 10.1186/s12959-021-00270-1.
本文引用的文献
1
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.产志贺毒素大肠杆菌与溶血尿毒综合征
Lancet. 2005;365(9464):1073-86. doi: 10.1016/S0140-6736(05)71144-2.
2
von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.100例血栓性血小板减少性紫癜患者的血管性血友病因子裂解蛋白酶（ADAMTS - 13）及ADAMTS - 13中和性自身抗体
Br J Haematol. 2004 Nov;127(4):433-9. doi: 10.1111/j.1365-2141.2004.05217.x.
3
Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).利妥昔单抗用于治疗难治性/复发性血栓性血小板减少性紫癜（TTP）。
Am J Hematol. 2004 Oct;77(2):171-6. doi: 10.1002/ajh.20166.
4
Proteolytic inactivation of ADAMTS13 by thrombin and plasmin.凝血酶和纤溶酶对ADAMTS13的蛋白水解失活作用。
Blood. 2005 Feb 1;105(3):1085-93. doi: 10.1182/blood-2004-03-1101. Epub 2004 Sep 23.
5
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin.伴有明显ADAMTS13抑制剂的致命性先天性血栓性血小板减少性紫癜：血红蛋白对ADAMTS13活性的体外抑制作用
Blood. 2005 Jan 15;105(2):542-4. doi: 10.1182/blood-2004-06-2096. Epub 2004 Sep 14.
6
Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).血栓性血小板减少性紫癜/溶血性尿毒症综合征（TTP/HUS）中的两种新型ADAMTS13基因突变。
Kidney Int. 2004 Sep;66(3):955-8. doi: 10.1111/j.1523-1755.2004.00841.x.
7
Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident.以急性脑血管意外为表现的复发性血栓性血小板减少性紫癜
J Clin Apher. 2004;19(2):86-9. doi: 10.1002/jca.20007.
8
Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.血管性血友病因子的血浆水平调节其主要裂解蛋白酶ADAMTS-13。
Br J Haematol. 2004 Jul;126(2):213-8. doi: 10.1111/j.1365-2141.2004.05009.x.
9
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement.成人特发性血栓性微血管病中严重的ADAMTS13缺乏定义了一组患者，其特征为各种自身免疫表现、较低的血小板计数和轻度肾受累。
Medicine (Baltimore). 2004 Jul;83(4):233-244. doi: 10.1097/01.md.0000133622.03370.07.
10
Challenges in the management of infantile factor H associated hemolytic uremic syndrome.婴儿因子H相关性溶血尿毒综合征的管理挑战
Pediatr Nephrol. 2004 Aug;19(8):908-11. doi: 10.1007/s00467-004-1526-9. Epub 2004 Jun 16.
Zotero 插件